- US-listed companies
- iSpecimen Inc.
- Income statement
iSpecimen Inc. (ISPC) Income statement
Market cap
$155.13M
P/E ratio
| 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Revenue | 11 | 10 | 10 | 9 | 2 |
| Revenue growth (%) | - | ||||
| Cost of revenue | 5 | 5 | 5 | 5 | 2 |
| Operating margin (%) | |||||
| Operating expenses | 17 | 21 | 21 | 22 | 11 |
| Operating income | -5,925,246 | -10,186,082 | -11,169,349 | -12,728,045 | -8,977,919 |
| Net income | -8,961,815 | -10,245,922 | -11,099,488 | -12,497,805 | -10,487,532 |
| Net income margin (%) | |||||
| Earnings per share | -2.09 | -1.16 | -1.23 | -17.58 | -2.28 |
| Diluted EPS | -2.09 | -1.16 | -1.23 | -17.58 | -2.28 |